Imran Khan et al.
Methods in molecular biology (Clifton, N.J.), 2262, 281-302 (2021-05-13)
RAS is frequently mutated in human cancers with nearly 20% of all cancers harboring mutations in one of three RAS isoforms (KRAS, HRAS, or NRAS). Furthermore, RAS proteins are critical oncogenic drivers of tumorigenesis. As such, RAS has been a